JAK2 and colorectal carcinoma: Indeed, we show that combined inhibition of BRD4 and IL6/8-JAK2 signaling is required to inhibit oncogene expression more completely, reversed the BETi resistance in vitro, and suppress the CRC xenograft tumor growth empowered by CAF in vivo.